Paradeep Phosphates (PARADEEP) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
19 May, 2026Executive summary
Revenue from operations grew 29% year-over-year to INR 21,826 crore (Rs. 218,263 Mn) for FY 2026, with EBITDA up 33% to INR 2,259 crore (Rs. 22,594 Mn) and PAT up 52% to INR 1,000 crore (Rs. 10,008 Mn).
Q4 revenue was INR 4,702 crore (Rs. 47,418 Mn), EBITDA INR 484 crore (Rs. 4,842 Mn), and PAT INR 161 crore (Rs. 1,611 Mn).
Production volumes increased 8% year-over-year to 36.66 lakh metric tons (3,666,291 MT), with nearly 100% capacity utilization.
Sales volumes rose 10% year-over-year to 42.1 lakh metric tons (4,209,890 MT), led by strong NPK and value-added product performance.
Audited results reflect the impact of a major merger with Mangalore Chemicals & Fertilizers Limited effective April 1, 2024.
Financial highlights
Profit before tax increased 46% year-over-year to INR 1,328 crore (Rs. 13,280 Mn).
EBITDA per ton for FY 2026 was INR 5,300; Q4 EBITDA per ton was INR 5,700.
Standalone revenue for FY 2025-26 was Rs. 21,972.92 crore, with standalone net profit at Rs. 996.84 crore.
Basic EPS for FY26 was 9.60, up 50.2% year-over-year.
Operating cash flow was negative INR 1,000 crore, mainly due to higher inventories and receivables, expected to normalize in Q1 FY 2027.
Outlook and guidance
Optimism for fertilizer demand continues, supported by government focus on soil health and balanced nutrient application.
Plans to double phosphoric acid capacity from 0.5 MMTPA to 1 MMTPA are on track, targeting 100% backward integration.
Raw material prices, especially ammonia and sulfur, remain volatile due to Middle East tensions; Q1 raw material needs are covered, with Q2 visibility being worked on.
Backward integration and energy efficiency projects are expected to improve margins in FY 2027.
No specific revenue or EBITDA margin guidance for FY 2027 due to ongoing volatility.
Latest events from Paradeep Phosphates
- Profitability improved despite lower Q1 volumes; new launches and merger progress support outlook.PARADEEP
Q1 24/259 Feb 2026 - Revenue and profit soared on higher volumes, MCFL merger, and expansion, with strong outlook.PARADEEP
Q3 25/264 Feb 2026 - Q3 FY25 delivered strong revenue and profit growth, with expansion and merger plans advancing.PARADEEP
Q3 24/2519 Dec 2025 - H1 FY26 profit surged 134.7% YoY, supported by MCFL merger and major capacity expansion.PARADEEP
Q2 25/2619 Dec 2025 - Record profit and sales growth, strong cash flow, and capacity expansion ahead.PARADEEP
Q4 24/2519 Dec 2025 - Q1 FY26 saw 58% revenue growth, margin expansion, and MCFL merger progress.PARADEEP
Q1 25/2619 Dec 2025 - Q2 FY25 profit soared 155% YoY, with major phosphoric acid expansion approved.PARADEEP
Q2 24/2519 Dec 2025